Larch Arabinogalactan Approved for Australian SupplementsLarch Arabinogalactan Approved for Australian Supplements
June 6, 2012
BASEL, SwitzerlandThe Australian monograph for larch arabinogalactan was updated to allow its use in dietary supplements. The revision, made by the Australian Governments Department of Health and Ageing, and Therapeutic Goods Administration (TGA), means companies can now market the ingredient in supplements to the Australian public.
Larch arabinogalactan is commonly marketed as benefiting immune health, and a 2010 study on ResistAid (a larch arabinogalactan ingredient from Lonza) increased the antibody response of healthy volunteers to the 23-valent pneumococcal vaccine compared to placebo.
You May Also Like
Collagen peptide ingredient solutions for seniors’ changing needs – infographicSep 19, 2023
Radicle Insights—Covid Eris and dietary supplements: separating fact from fictionSep 21, 2023
More bioavailable hyaluronic acid complex for today’s beauty-from-within consumer – snapshotSep 18, 2023
Herbalife launches fitness campaign as it strives to regain sales momentumSep 20, 2023